Moreover, there may be a minimum threshold at which the MET/CEP7 ratio confers MET dependency and sensitivity to AMG 208, similar to recent reports of HER-2 and trastuzumab in gastric cancer [23]. This evidence concerns the gene ERBB2 and gastric cancer.